Contribution: Industrial Research Assistance Program – Contributions to Firms
Angany inc.
$162,000.00
Feasibility - Development of mutanoma vaccines
FY 2023-24 · 2023-08-14
Summary
Development of a curative cancer vaccine platform to elicit a personalized immune response against cancer cells
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Levis|Lévis, Quebec, Canada
Recipient Type
For-profit organization
Business Number
778574087
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-08-14 | 2023-24 | $162,000.00 |
| 1 | 2023-08-14 | 2023-24 | $162,000.00 |
| 2 | 2023-08-14 | 2023-24 | $162,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 212 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 212 jours.
Agreement End Date
2025-07-31
Agreement Number
1008613
Agreement Start Date
2023-08-14
Agreement Title
Feasibility - Development of mutanoma vaccines
Agreement Title (French)
Faisabilité — Développement de vaccins contre le mutanome
Agreement Type
Contribution
Agreement Value
$162,000.00
Amendment Date
2024-12-04
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of a curative cancer vaccine platform to elicit a personalized immune response against cancer cells
Description (French)
Développement d’une plateforme de vaccins curatifs contre le cancer permettant de déclencher une réponse immunitaire personnalisée contre les cellules cancéreuses.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Bellechasse--Les Etchemins--Lévis
Federal Riding (French)
Bellechasse--Les Etchemins--Lévis
Federal Riding Number
24010
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
778574087
Recipient City
Levis|Lévis
Recipient Country
CA
Recipient Legal Name
Angany inc.
Recipient Postal Code
G6W 0L9
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2023-2024-Q2-1008613
